These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6696722)

  • 1. Thymidylate synthetase-deficient mouse FM3A mammary carcinoma cell line as a tool for studying the thymidine salvage pathway and the incorporation of thymidine analogues into host cell DNA.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Biochem J; 1984 Jan; 217(1):245-52. PubMed ID: 6696722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line.
    Balzarini J; De Clercq E; Ayusawa D; Seno T
    Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymidylate synthetase-positive and -negative murine mammary FM3A carcinoma cells as a useful system for detecting thymidylate synthetase inhibitors.
    Balzarini J; de Clercq E; Ayusawa D; Seno T
    FEBS Lett; 1984 Jul; 173(1):227-32. PubMed ID: 6745430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cytostatic action of novel 5-(thien-2-yl)- and 5-(furan-2-yl)-substituted pyrimidine nucleoside analogues against tumor cells transfected by the thymidine kinase gene of herpes simplex virus.
    Bohman C; Balzarini J; Wigerinck P; Van Aerschot A; Herdewijn P; De Clercq E
    J Biol Chem; 1994 Mar; 269(11):8036-43. PubMed ID: 8132526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Substituted 2'-deoxyuridines: correlation between inhibition of tumor cell growth and inhibition of thymidine kinase and thymidylate synthetase.
    Balzarini J; De Clercq E; Mertes MP; Shugar D; Torrence PF
    Biochem Pharmacol; 1982 Nov; 31(22):3673-82. PubMed ID: 7181950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Biochim Biophys Acta; 1984 Feb; 785(1-2):36-45. PubMed ID: 6696920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of thymidine kinase and thymidylate synthase in intact human lymphoblast CCRF-CEM cells.
    Xu YZ; Plunkett W
    J Biol Chem; 1993 Oct; 268(30):22363-8. PubMed ID: 8226747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to methotrexate in thymidylate synthetase-deficient mutants of cultured mouse mammary tumor FM3A cells.
    Ayusawa D; Koyama H; Seno T
    Cancer Res; 1981 Apr; 41(4):1497-501. PubMed ID: 6452198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
    Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
    Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
    Jackman AL; Taylor GA; Calvert AH; Harrap KR
    Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
    Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
    Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of 5-nitro-2'-deoxyuridine.
    Washtien WL; Santi DV
    J Med Chem; 1982 Oct; 25(10):1252-5. PubMed ID: 6183429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-step selection of mouse FM3A cell mutants defective in thymidylate synthetase.
    Ayusawa D; Koyama H; Iwata K; Seno T
    Somatic Cell Genet; 1980 Mar; 6(2):261-70. PubMed ID: 6994265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates.
    Houghton PJ; Rahman A; Will CL; Dolnick BJ; Houghton JA
    Cancer Res; 1992 Feb; 52(3):558-65. PubMed ID: 1732043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity analysis of antagonism of the feedback inhibition of thymidine kinase.
    Fischer PH; Fang TT; Lin TS; Hampton A; Bruggink J
    Biochem Pharmacol; 1988 Apr; 37(7):1293-8. PubMed ID: 3355601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.
    Yalowich JC; Kalman TI
    Biochem Pharmacol; 1985 Jul; 34(13):2319-24. PubMed ID: 3160352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
    Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
    Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.
    Moran RG; Mulkins M; Heidelberger C
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5924-8. PubMed ID: 160558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.